Triple
T2190612
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Remicade |
E49851
|
entity |
| Predicate | isOftenUsedWith |
P4791
|
FINISHED |
| Object |
methotrexate
Methotrexate is a disease-modifying antirheumatic drug (DMARD) commonly used to treat autoimmune conditions such as rheumatoid arthritis, psoriasis, and certain cancers by inhibiting folate-dependent cell proliferation.
|
E242406
|
NE FINISHED |
How this triple was built (5 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: methotrexate | Statement: [Remicade, isOftenUsedWith, methotrexate]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: methotrexate Context triple: [Remicade, isOftenUsedWith, methotrexate]
-
A.
Remicade
Remicade is a widely used monoclonal antibody biologic (infliximab) prescribed to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
-
B.
Rituxan
Rituxan is a monoclonal antibody drug (rituximab) widely used to treat certain blood cancers and autoimmune diseases by targeting the CD20 protein on B cells.
-
C.
Stelara
Stelara is a prescription biologic medication (ustekinumab) used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and Crohn’s disease by targeting specific immune system pathways.
-
D.
Actemra
Actemra is a prescription biologic medication (tocilizumab) used to treat inflammatory conditions such as rheumatoid arthritis by inhibiting the interleukin-6 (IL-6) receptor.
-
E.
Taltz
Taltz is a prescription biologic medication (ixekizumab) used to treat moderate to severe plaque psoriasis and certain types of arthritis by targeting the inflammatory protein IL-17A.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: methotrexate Triple: [Remicade, isOftenUsedWith, methotrexate]
Generated description
Methotrexate is a disease-modifying antirheumatic drug (DMARD) commonly used to treat autoimmune conditions such as rheumatoid arthritis, psoriasis, and certain cancers by inhibiting folate-dependent cell proliferation.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: methotrexate Target entity description: Methotrexate is a disease-modifying antirheumatic drug (DMARD) commonly used to treat autoimmune conditions such as rheumatoid arthritis, psoriasis, and certain cancers by inhibiting folate-dependent cell proliferation.
-
A.
Remicade
Remicade is a widely used monoclonal antibody biologic (infliximab) prescribed to treat autoimmune inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis.
-
B.
Rituxan
Rituxan is a monoclonal antibody drug (rituximab) widely used to treat certain blood cancers and autoimmune diseases by targeting the CD20 protein on B cells.
-
C.
Stelara
Stelara is a prescription biologic medication (ustekinumab) used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and Crohn’s disease by targeting specific immune system pathways.
-
D.
Actemra
Actemra is a prescription biologic medication (tocilizumab) used to treat inflammatory conditions such as rheumatoid arthritis by inhibiting the interleukin-6 (IL-6) receptor.
-
E.
Taltz
Taltz is a prescription biologic medication (ixekizumab) used to treat moderate to severe plaque psoriasis and certain types of arthritis by targeting the inflammatory protein IL-17A.
- F. None of above. chosen
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: isOftenUsedWith Context triple: [Remicade, isOftenUsedWith, methotrexate]
-
A.
usedWith
chosen
Indicates that one entity is typically or appropriately employed together with another entity in a combined or complementary use.
-
B.
areUsedIn
Indicates that certain entities serve as components, tools, or resources within a particular process, context, or application.
-
C.
widelyUsedIn
Indicates that something is commonly or extensively utilized within a particular context, domain, or group.
-
D.
areUsedBy
Indicates that certain entities serve as tools, resources, or means that are utilized or employed by other entities.
-
E.
alsoUsedIn
Indicates that something is additionally employed, applied, or present in another context, setting, or use case beyond the primary one.
- F. None of above.
Provenance (6 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a88aaba3c48190b351cab9b26989ff |
completed | March 4, 2026, 7:40 p.m. |
| NER | Named-entity recognition | batch_69abbf9e99f08190892d34485c8f2f25 |
completed | March 7, 2026, 6:03 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ae5db0352c8190aa9c4c58460df3a4 |
completed | March 9, 2026, 5:42 a.m. |
| NEDg | Description generation | batch_69ae5e5fe37c8190bcf73200d32f5faa |
completed | March 9, 2026, 5:45 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69ae5ed1e3208190b46d5e8361c2a5f6 |
completed | March 9, 2026, 5:46 a.m. |
| PD | Predicate disambiguation | batch_69abbda32d1881909d1fd83a751fb21c |
completed | March 7, 2026, 5:54 a.m. |
Created at: March 4, 2026, 7:46 p.m.